Pall Corp. (PLL) said it has signed a definitive merger agreement to buy ForteBio, Inc., a provider of advanced analytical systems that accelerate the discovery and development of biotech drugs. Terms of the deal were not disclosed.
Pall expects the transaction to close by February of 2012. Upon closing, ForteBio will become a wholly-owned subsidiary of Pall Corp. In the short term, the impact to Pall's results of operations will be immaterial.
by RTT Staff Writer
For comments and feedback: email@example.com